Lyme disease vaccine - Antigenics
Latest Information Update: 24 Oct 2021
At a glance
- Originator Antigenics
- Class Bacterial vaccines; Lyme disease vaccines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Discontinued Lyme disease
Most Recent Events
- 19 Aug 1999 New profile, split from generic Lyme disease vaccine profile
- 19 Aug 1999 Discontinued-Preclinical for Lyme disease in USA (Unknown route)